Health care stocks rose Thursday with the NYSE Health Care Index up 1% and the Health Care Select Sector SPDR Fund (XLV) adding 1.2%.
The iShares Biotechnology ETF (IBB) advanced 1%.
In corporate news, Kazia Therapeutics' (KZIA) shares jumped 38% after the company announced the regulatory approval and launch of a trial evaluating the combination of its investigational drug paxalisib and immunotherapy in people with advanced breast cancer.
Valneva (VALN) shares rose 3.6% after the company won a $32.8 million contract from the US Department of Defense for the supply of Ixiaro, a Japanese encephalitis vaccine.
Ironwood Pharmaceuticals (IRWD) shares slumped 38%, a day after the company announced a 50% cut in its workforce due to "ongoing pricing pressures."
Cargo Therapeutics (CRGX) shares tumbled 74%, a day after the company announced plans to discontinue a phase 2 trial of firicabtagene autoleucel for people with large B-cell lymphoma and reduce its workforce by 50%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。